4/A: Semler Scientific Director Transfers Shares to Family Trust

Sentiment:

SEC Form 4/A Filing


William H. Chang, a director at Semler Scientific, transferred 2,182 shares of common stock to his family trust as part of a director compensation award.

Summary

  • William H. Chang, a director at Semler Scientific, received 2,182 shares of common stock as part of his non-employee director compensation.
  • These shares were fully vested upon grant on May 10, 2024.
  • The director immediately gifted these shares to the W&D Chang Family Trust.
  • As a result of this transaction, the director no longer holds these shares directly, but they are now held indirectly through the family trust.
  • This filing is an amendment to a previous filing on May 14, 2024, to reflect the transfer of shares to the family trust.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation and does not indicate any significant positive or negative sentiment. It is a standard process.

Positives

  • The director compensation policy is being executed as expected.
  • The shares were fully vested upon grant, indicating immediate value for the director.

Industry Context

This is a routine transaction related to director compensation and is common practice for publicly traded companies.

Comparison to Industry Standards

  • Director compensation in the form of stock awards is a standard practice among publicly traded companies.
  • The immediate vesting of shares is also a common practice to align director interests with shareholder value.
  • The transfer of shares to a family trust is a common estate planning strategy for directors and executives.

Related Party Transactions

  • The transfer of shares to the W&D Chang Family Trust is a related party transaction.

Stakeholder Impact

  • The transaction has a minimal impact on shareholders as it is a transfer of existing shares and not a new issuance.
  • The transaction does not impact employees, customers, suppliers, or creditors.

Key Dates

DateDescription
05/10/2024Date of the share award and transfer to the family trust.
05/14/2024Date of the original filing that this document amends.
01/07/2025Date of signature of the attorney-in-fact.

Keywords

Semler Scientific, director compensation, share transfer, family trust, beneficial ownership, insider transaction, equity securities

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.